Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease.
Saved in:
| Title: | Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease. |
|---|---|
| Authors: | Cáceres Medina JL; Internal Medicine, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX., González Torres LA; Internal Medicine, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX., Gamboa-Meza A; Pulmonary and Critical Care Medicine/Internal Medicine, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX., Cantu-Rodriguez OG; Hematology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX. |
| Source: | Cureus [Cureus] 2024 Apr 26; Vol. 16 (4), pp. e59080. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.59080 |
